MLL-aberrant leukemia: complete cytogenetic remission following treatment with a histone deacetylase inhibitor (HDACi).
Kate L
KL
Burbury
Mark J
MJ
Bishton
Ricky W
RW
Johnstone
Michael J
MJ
Dickinson
Jeffrey
J
Szer
H Miles
HM
Prince
D000328:Adult; D056572:Histone Deacetylase Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007938:Leukemia / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D051788:Myeloid-Lymphoid Leukemia Protein / Q000235:genetics*; D012074:Remission Induction; D016896:Treatment Outcome
D056572:Histone Deacetylase Inhibitors; D051788:Myeloid-Lymphoid Leukemia Protein